<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="28539">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02735200</url>
  </required_header>
  <id_info>
    <org_study_id>DammamU</org_study_id>
    <nct_id>NCT02735200</nct_id>
  </id_info>
  <brief_title>Topical Delivery of Vitamin D3 as Vitamin D Supplementation</brief_title>
  <official_title>Topical Delivery of Vitamin D3: A Randomized Controlled Trial (RCT)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dammam University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Dammam University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      After obtaining the approval from the IRB of University of Dammam and informed consent from
      550 healthy patients, with vitamin D deficiency and vitamin D insufficiency and deficiency
      were recruited. Age, weight and height will be taken, a detailed history, meticulous
      clinical examination was performed to rule out any diseases and complete blood picture,
      serum calcium, phosphorous, alkaline phosphatase, Parathormone and 25 Hydroxy-vitamin D
      (25OHD) will be done. 25-Hydroxy Vitamin D3 was measured in house by chemiluminescence
      immunoassay (CLIA) and ≥30ng/mL was taken as normal, 21-29ng/mL as insufficiency and ≤20
      ng/mL as deficiency. The participants were divided into two groups of 350 in study arm and
      200 in control arm. All participants were instructed not to change their dietary habits and
      life style till the study was over. The study group of women were instructed to apply to
      apply Top-D (Proniosomal Delivered- Vitamin D3) 1 gram containing 5000 IU of vitamin D3. The
      second group used 1 gram of Aloe vera gel. The participants had no knowledge to which group
      they belong. A second blood sample was taken at the end of 4 months and the data was entered
      in the data base and analyzed using SPSS Inc version 19.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After obtaining the approval from the Institutional Review Board (IRB) of University of
      Dammam and informed consent from 550 healthy patients, with vitamin D deficiency and vitamin
      D insufficiency and deficiency were recruited. Age, weight and height will be taken, a
      detailed history, meticulous clinical examination was performed to rule out any diseases and
      complete blood picture, serum calcium, phosphorous, alkaline phosphatase, Parathormone and
      25 Hydroxy-vitamin D (25OHD) will be done. 25-Hydroxy Vitamin D3 was measured in house by
      chemiluminescence immunoassay (CLIA) and ≥30ng/mL was taken as normal, 21-29ng/mL as
      insufficiency and ≤20 ng/mL as deficiency. The participants were divided into two groups of
      350 in study arm and 200 in control arm. All participants were instructed not to change
      their dietary habits and life style till the study was over. The study group of women were
      instructed to apply to apply Top-D (Proniosomal Delivered- Vitamin D3) I gram gram
      containing 5000 IU of vitamin D3. The second group used 1 gram of Aloe vera gel. The
      participants had no knowledge to which group they belong. A second blood sample was taken at
      the end of 4 months and the data was entered in the data base and analyzed using SPSS Inc
      version 19.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Anticipated">January 2017</completion_date>
  <primary_completion_date type="Actual">January 2017</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>No masking</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in the serum levels of 25OHD after 4 months of treatment with topical Vitamin D3.</measure>
    <time_frame>4 months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">550</enrollment>
  <condition>Vitamin D Deficiency</condition>
  <arm_group>
    <arm_group_label>topical application of vitamin D3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention: 350 patients will be administered topical vitamin D3 5000 IU</description>
  </arm_group>
  <arm_group>
    <arm_group_label>application of aloe vera gel</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Intervention: aloe vera gel administration</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>topical vitamin D3 in intervention group</intervention_name>
    <description>local application</description>
    <arm_group_label>topical application of vitamin D3</arm_group_label>
    <arm_group_label>application of aloe vera gel</arm_group_label>
    <other_name>topical vitamin D3</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        all men and women with vitamin D insufficiency and deficiency Must be able to apple the
        topical vitamin D3 Must be willing to sign and informed consent

        Exclusion Criteria:

          -  Those who have normal 25OHD levels
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Naif AlMasoud, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>University of Dammam, Saudi Arabia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mir Sadat-Ali, MS, FRCS</last_name>
    <phone>+966505848281</phone>
    <email>drsadat@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Haifa A AlTurki, MD, ABOG</last_name>
    <phone>+966505869021</phone>
    <email>haalturki@uod.edu.sa</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>King Fahd Hospital of the University</name>
      <address>
        <city>AlKhobar</city>
        <zip>31952</zip>
        <country>Saudi Arabia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mir Sadat-Ali, MD, FRCS</last_name>
      <phone>+966505848281</phone>
      <email>drsadat@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Saudi Arabia</country>
  </location_countries>
  <reference>
    <citation>Sanfelix-Genovés J, Gil-Guillén VF, Orozco-Beltran D, Giner-Ruiz V, Pertusa-Martínez S, Reig-Moya B, Carratalá C. Determinant factors of osteoporosis patients' reported therapeutic adherence to calcium and/or vitamin D supplements: a cross-sectional, observational study of postmenopausal women. Drugs Aging. 2009;26(10):861-9. doi: 10.2165/11317070-000000000-00000.</citation>
    <PMID>19761279</PMID>
  </reference>
  <results_reference>
    <citation>Sadat-Ali M, Bubshait DA, Al-Turki HA, Al-Dakheel DA, Al-Olayani WS. Topical delivery of vitamin d3: a randomized controlled pilot study. Int J Biomed Sci. 2014 Mar;10(1):21-4.</citation>
    <PMID>24711745</PMID>
  </results_reference>
  <results_reference>
    <citation>Riccio PA, Zingaretti C, Milani M, Ricci Petitoni G, Monti G, Pavanello PM. [Thymoma: diagnosis and surgical treatment]. Minerva Chir. 1996 Sep;51(9):663-7. Italian.</citation>
    <PMID>9082230</PMID>
  </results_reference>
  <results_reference>
    <citation>Sadat-Ali M, AlElq A, Al-Turki H, Al-Mulhim F, Al-Ali A. Vitamin D levels in healthy men in eastern Saudi Arabia. Ann Saudi Med. 2009 Sep-Oct;29(5):378-82.</citation>
    <PMID>19700896</PMID>
  </results_reference>
  <results_reference>
    <citation>Elsammak MY, Al-Wosaibi AA, Al-Howeish A, Alsaeed J. Vitamin d deficiency in Saudi Arabs. Horm Metab Res. 2010 May;42(5):364-8. doi: 10.1055/s-0030-1248296. Epub 2010 Mar 8.</citation>
    <PMID>20213587</PMID>
  </results_reference>
  <results_reference>
    <citation>Al-Elq AH. The status of Vitamin D in medical students in the preclerkship years of a Saudi medical school. J Family Community Med. 2012 May;19(2):100-4. doi: 10.4103/2230-8229.98293.</citation>
    <PMID>22870413</PMID>
  </results_reference>
  <results_reference>
    <citation>Grant AM, Avenell A, Campbell MK, McDonald AM, MacLennan GS, McPherson GC, Anderson FH, Cooper C, Francis RM, Donaldson C, Gillespie WJ, Robinson CM, Torgerson DJ, Wallace WA; RECORD Trial Group.. Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial. Lancet. 2005 May 7-13;365(9471):1621-8.</citation>
    <PMID>15885294</PMID>
  </results_reference>
  <results_reference>
    <citation>Porthouse J, Cockayne S, King C, Saxon L, Steele E, Aspray T, Baverstock M, Birks Y, Dumville J, Francis R, Iglesias C, Puffer S, Sutcliffe A, Watt I, Torgerson DJ. Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care. BMJ. 2005 Apr 30;330(7498):1003.</citation>
    <PMID>15860827</PMID>
  </results_reference>
  <results_reference>
    <citation>Jackson RD, LaCroix AZ, Gass M, Wallace RB, Robbins J, Lewis CE, Bassford T, Beresford SA, Black HR, Blanchette P, Bonds DE, Brunner RL, Brzyski RG, Caan B, Cauley JA, Chlebowski RT, Cummings SR, Granek I, Hays J, Heiss G, Hendrix SL, Howard BV, Hsia J, Hubbell FA, Johnson KC, Judd H, Kotchen JM, Kuller LH, Langer RD, Lasser NL, Limacher MC, Ludlam S, Manson JE, Margolis KL, McGowan J, Ockene JK, O'Sullivan MJ, Phillips L, Prentice RL, Sarto GE, Stefanick ML, Van Horn L, Wactawski-Wende J, Whitlock E, Anderson GL, Assaf AR, Barad D; Women's Health Initiative Investigators.. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med. 2006 Feb 16;354(7):669-83. Erratum in: N Engl J Med. 2006 Mar 9;354(10):1102.</citation>
    <PMID>16481635</PMID>
  </results_reference>
  <results_reference>
    <citation>Nikolaus T, Kruse W, Bach M, Specht-Leible N, Oster P, Schlierf G. Elderly patients' problems with medication. An in-hospital and follow-up study. Eur J Clin Pharmacol. 1996;49(4):255-9.</citation>
    <PMID>8857069</PMID>
  </results_reference>
  <results_reference>
    <citation>Thomas BJ, Finnin BC. The transdermal revolution. Drug Discov Today. 2004 Aug 15;9(16):697-703. Review.</citation>
    <PMID>15341783</PMID>
  </results_reference>
  <results_reference>
    <citation>Shi Y, Wei Z, Zhao H, Liu T, Dong A, Zhang J. Electrospinning of ibuprofen-loaded composite nanofibers for improving the performances of transdermal patches. J Nanosci Nanotechnol. 2013 Jun;13(6):3855-63.</citation>
    <PMID>23862418</PMID>
  </results_reference>
  <results_reference>
    <citation>Derry S, Moore RA. Topical capsaicin (low concentration) for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2012 Sep 12;(9):CD010111. doi: 10.1002/14651858.CD010111. Review.</citation>
    <PMID>22972149</PMID>
  </results_reference>
  <results_reference>
    <citation>Aggarwal N, Goindi S. Preparation and in vivo evaluation of solid lipid nanoparticles of griseofulvin for dermal use. J Biomed Nanotechnol. 2013 Apr;9(4):564-76.</citation>
    <PMID>23621015</PMID>
  </results_reference>
  <results_reference>
    <citation>Ahad A, Al-Jenoobi FI, Al-Mohizea AM, Aqil M, Kohli K. Transdermal delivery of calcium channel blockers for hypertension. Expert Opin Drug Deliv. 2013 Aug;10(8):1137-53. doi: 10.1517/17425247.2013.783562. Epub 2013 Mar 26. Review.</citation>
    <PMID>23527660</PMID>
  </results_reference>
  <results_reference>
    <citation>Goodman MP. Are all estrogens created equal? A review of oral vs. transdermal therapy. J Womens Health (Larchmt). 2012 Feb;21(2):161-9. doi: 10.1089/jwh.2011.2839. Epub 2011 Oct 19. Review.</citation>
    <PMID>22011208</PMID>
  </results_reference>
  <results_reference>
    <citation>Segal E, Zinman C, Raz B, Ish-Shalom S. Low patient compliance--a major negative factor in achieving vitamin D adequacy in elderly hip fracture patients supplemented with 800IU of vitamin D3 daily. Arch Gerontol Geriatr. 2009 Nov-Dec;49(3):364-7. doi: 10.1016/j.archger.2008.12.001. Epub 2009 Jan 14.</citation>
    <PMID>19147237</PMID>
  </results_reference>
  <results_reference>
    <citation>Castelo-Branco C, Cortés X, Ferrer M; UNICAD study investigators.. Treatment persistence and compliance with a combination of calcium and vitamin D. Climacteric. 2010 Dec;13(6):578-84. doi: 10.3109/13697130903452804. Epub 2009 Dec 1.</citation>
    <PMID>19951084</PMID>
  </results_reference>
  <verification_date>January 2017</verification_date>
  <lastchanged_date>January 23, 2017</lastchanged_date>
  <firstreceived_date>March 12, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Vitamin D Deficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
